SCHEMBL699765

SCHEMBL699765

Cc1c(F)c(F)cc(S(=O)(=O)Cl)c1F

nearest known ligand 0.34

Predicted protein targets (top 6)

geneUniProtsupporting neighboursconfidence
CA12 O43570 1/20 0.34
CA1 P00915 1/20 0.34
CA2 P00918 1/20 0.34
CA7 P43166 1/20 0.34
CA13 Q8N1Q1 1/20 0.34
TRPV4 Q9HBA0 2/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5146719 0.83 TRPV4 (0.32) CA12CA1CA2CA7CA13
SCHEMBL4432860 0.83 CA12 (0.34) CA12CA1CA2CA7CA13
SCHEMBL1535900 0.80 CA12 (0.38) CA12CA1CA2CA7CA13
SCHEMBL29671274 0.80 CA12 (0.38) CA12CA1CA2CA7CA13
SCHEMBL27138022 0.75 TRPV4 (0.39) TRPV4
SCHEMBL30681724 0.75 TRPV4 (0.39) TRPV4
SCHEMBL4134828 0.75 TRPV4 (0.39) TRPV4
SCHEMBL1816654 0.75 TRPV4 (0.40) CA12CA1CA2CA7CA13
SCHEMBL20401479 0.74 CES2 (0.40) CA12CA1CA2CA7CA13
SCHEMBL17056174 0.74 PTGS2 (0.33) TRPV4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8318769-B2 Substituted sulfonamide compounds GRUENETHAL GMBH (DE) 2012-11-27 US disclosed
US-8124624-B2 Substituted sulfonamide compounds GRUENENTHAL GMBH (DE) 2012-02-28 US disclosed
US-20090264407-A1 Substituted Sulfonamide Compounds GRUENENTHAL GMBH (DE) 2009-10-22 US disclosed
US-20090264400-A1 Substituted Sulfonamide Compounds GRUENENTHAL GMBH (DE) 2009-10-22 US disclosed
US-7414134-B2 B1 bradykinin receptor antagonists AMGEN INC. (US) 2008-08-19 US disclosed
US-7365042-B2 Pyridine-3-sulfonyl compounds as pesticidal agents BASF AKTIENGESELLSCHAFT (DE) 2008-04-29 US disclosed
EP-1817306-A1 TRIAZOLES AND THEIR USE AS BRADYKININ B1 RECEPTOR ANTAGONISTS Amgen, Inc (US) 2007-08-15 EP disclosed
EP-1802612-A1 NOVEL B1 BRADYKININ RECEPTOR ANTAGONISTS Amgen, Inc (US) 2007-07-04 EP disclosed
US-20060167264-A1 Pyridine-3-sulfonyl compounds as pesticidal agents BASF AKTIENGESELLSCHAFT (DE) 2006-07-27 US disclosed
US-20060100213-A1 Triazoles and methods of use AMGEN INC. (US) 2006-05-11 US disclosed
US-20060100216-A1 Novel B1 bradykinin receptor antagonists AMGEN INC. (US) 2006-05-11 US disclosed
WO-2006044412-A1 NOVEL B1 BRADYKININ RECEPTOR ANTAGONISTS AMGEN INC. (US) 2006-04-27 WO disclosed
WO-2006044355-A1 TRIAZOLES AND THEIR USE AS BRADYKININ B1 RECEPTOR ANTAGONISTS AMGEN INC. (US) 2006-04-27 WO disclosed
EP-1453808-B1 PYRIDINE-3-SULFONYL COMPOUNDS AS PESTICIDAL AGENTS BASF AG (DE) 2006-02-01 EP disclosed
EP-1453808-A1 PYRIDINE-3-SULFONYL COMPOUNDS AS PESTICIDAL AGENTS BASF AKTIENGESELLSCHAFT (DE) 2004-09-08 EP disclosed
WO-2003043990-A1 PYRIDINE-3-SULFONYL COMPOUNDS AS PESTICIDAL AGENTS BASF AKTIENGESELLSCHAFT (DE) 2003-05-30 WO disclosed
EP-0306222-A2 Benzenesulfonanilide derivatives and fungicides for agriculture and horticulture HOKKO CHEMICAL INDUSTRY CO., LTD (JP) 1989-03-08 EP disclosed
EP-0008958-A1 Fluorinated benzenesulfonate diacetylenes, a composition containing a polymer derived from these monomers; the application of such compounds in time-temperature history monitoring devices ALLIED CORPORATION (US) 1980-03-19 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090264407-A1 Substituted Sulfonamide Compounds CNR1, SUCNR1, OPRL1 CA12 3278/4885CA1 3223/4885CA2 1864/4885
US-20060167264-A1 Pyridine-3-sulfonyl compounds as pesticidal agents GLRX3, ACHE, DDT CA12 4664/4885CA1 3459/4885CA2 1287/4885
US-20060100213-A1 Triazoles and methods of use CYP3A5, CYP3A43, CYP2E1 CA12 4075/4885CA1 3405/4885CA2 2170/4885
US-20060100216-A1 Novel B1 bradykinin receptor antagonists BDKRB1, BDKRB2, EDNRB CA12 3821/4885CA1 3708/4885CA2 3079/4885
US-20090264400-A1 Substituted Sulfonamide Compounds BDKRB1, BDKRB2, TRPV1 CA12 2157/4885CA1 1364/4885CA2 682/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.